Calitii, a Synechron company and IT consultancy, has announced a contract with BridgeBio, a biopharmaceutical company, to deliver comprehensive ServiceNow Managed Services.
The collaboration builds on Calitii's foundational ServiceNow IT Service Management implementation for BridgeBio last year, progressing towards day-to-day management, proactive upkeep, and continuous enhancement of the ServiceNow platform.
Under this partnership, Calitii will function as an extension of BridgeBio's internal IT framework. The managed service strategy is designed to keep the ServiceNow system agile, secure, and in tune with the dynamic needs of BridgeBio's business operations.
According to Patrick O’Connor, CEO at Calitii, a Synechron company, “Managing a complex ServiceNow environment demands a proactive approach, constant evolution and strategic insight to stay ahead of business demands." Their approach emphasises continual service improvements and platform optimisation to maintain consistent performance.
Nick Keenan, SVP, Head of IT at BridgeBio, emphasised the importance of an efficient digital infrastructure as the company scales. “Appointing Calitii, a Synechron company, to help manage our ServiceNow platform allows us to leverage their certified and experienced team’s industry knowledge and technical expertise in highly regulated markets."
The ServiceNow Managed Services agreement aims to provide the following core components:
- Proactive identification and implementation of service improvements to enhance platform efficacy, security, and reliability.
- A certified and seasoned support team handling enquiries, incidents, problems, enhancements, and requests.
- Strategic advisory with roadmap and strategy guidance to unlock full platform potential, including new feature deployment and AI integration.
- Thorough platform upkeep including upgrades, patches, health checks, and security assessments.
- A round-the-clock helpdesk offering operational support for user concerns and bug resolutions.
This collaboration aims to support platform performance, improve productivity, and contribute to BridgeBio’s strategic growth objectives.
